International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
Condition: COVID-19 Intervention: Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo; Partnership for Clinical Research in Guinea/Partenariat de Recherche Clinique en Guinée (PREGUI); National Institute of Health Resea rch and Development, Ministry of Health Republic of Indonesia; Partnership for Research on Ebola Virus in Liberia (PREVAIL); University Clinical Research Center, Mali; National Institute of Medical Sciences and Nutrition, Salvador Zubiran Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Congo Health | COVID-19 | Ebola | Ebola Vaccine | Guinea Health | Indonesia Health | Infectious Diseases | Liberia Health | Mali Health | National Institutes of Health (NIH) | Nutrition | Partnerships | Research | Study | Vaccines